Banner

Recombinant Human IGF1 Protein (Active)

Recombinant Human IGF1 Protein (Active) (RMPP-00230833)

Cat. No.: RMPP-00230833

Category: Growth Factors & Cytokines

Research Area: Signal Transduction

INQUIRY 500 μg 100 μg

Product Features

Source HEK 293 cells
Purity ≥ 95% SDS-PAGE. =95% Purity by HPLC.
Nature Recombinant
Endotoxin Level ≤ 0.005 Eu/µg
Animal Free Yes
Form Lyophilized
Applications SDS-PAGE; HPLC; MS; Functional Studies
Key Features Expression system: HEK 293 cells; Purity: ≥ 95% SDS-PAGE; Endotoxin level: ≤ 0.005 Eu/µg; Active: Yes; Suitable for: SDS-PAGE, HPLC, MS, Functional Studies

Protein Information

UniProt ID P05019
Molecular Weight 15 kDa
Molecular Weight Information Predicted MW is 15077.3 Da (+/- 10 Da by ESI-TOF). Observed MW is 15077.37. Multiple O-glycosylation sites are present in the sequence and presented in the mass analysis.
Sequence GPETLCGAEL VDALQFVCGP RGFYFNKPTG YGSSIRRAPQ TGIVDECCFR SCDLRRLEMY
CAPLKPTKAA RSIRAQRHTD MPKTQKSPSL STNKKTKLQR RRKGEPKTHP EGEQEEVTEA
TRKIRGPREK RLG
Sequence Similarities Belongs to the insulin family.
Protein Length Full length protein
Cellular Localization Secreted.
Function The insulin-like growth factors, isolated from plasma, are structurally and functionally related to insulin but have a much higher growth-promoting activity. May be a physiological regulator of -2-deoxy-D-glucose (2DG) transport and glycogen synthesis in osteoblasts. Stimulates glucose transport in rat bone-derived osteoblastic (PyMS) cells and is effective at much lower concentrations than insulin, not only regarding glycogen and DNA synthesis but also with regard to enhancing glucose uptake.
Involvement in Disease Defects in IGF1 are the cause of insulin-like growth factor I deficiency (IGF1 deficiency). IGF1 deficiency is an autosomal recessive disorder characterized by growth retardation, sensorineural deafness and mental retardation.

Storage & Shipping

Shipping and Storage Shipped at Room Temperature. Store at Room Temperature.
pH: 7.40Constituents: 0.727% Dibasic monohydrogen potassium phosphate, 0.248% Monobasic dihydrogen potassium phosphate, 10.26% TrehaloseBuffer lyophilized from.
This product is an active protein and may elicit a biological response in vivo, handle with caution.

For research use only. Not for clinical use.